All In MedTech

FDA Clearance Tracker · P080025-S083

VERIFY EVALUATION SYSTEM FOR INTERSTIM THERAPY FOR URINARY CONTROL AND BOWEL CONTROL

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 26, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 26, 2015

Approved

Time to decision

179 days

Received Dec 29, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P080025-S083
Device name
VERIFY EVALUATION SYSTEM FOR INTERSTIM THERAPY FOR URINARY CONTROL AND BOWEL CONTROL
Applicant location
Minneapolis, MN
Received
Dec 29, 2014
Decided
Jun 26, 2015
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P080025

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code QON

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE MODEL 3579 CABLE AND MODEL 3676 CABLE AND ASSOCIATED CHANGES TO ENABLE USE OF THE APPROVED VERIFY EVALUATION SYSTEM WITH THE APPROVED TEMPORARY TEST STIMULATION LEADS.

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.